Related Experiment Video

Updated: Aug 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

[Treatment of Flexner's dysentery with ofloxacin]

A G Rakhmanova, V P Kulikov

    Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
    |January 1, 1996
    PubMed

    Insights

    Ofloxacin effectively treats Shigella flexneri 2a dysentery, leading to rapid symptom improvement and pathogen eradication. This antibiotic demonstrated superior efficacy compared to other treatments in clinical trials.

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Pharmacology

    Background:

    • Dysentery caused by Shigella flexneri 2a is a significant public health concern.
    • Alternative antibiotic treatments for Shigella infections may have limitations in efficacy or resistance development.

    Purpose of the Study:

    • To evaluate the efficacy and clinical outcomes of ofloxacin in treating Shigella flexneri 2a dysentery.
    • To compare the effectiveness of different ofloxacin administration regimens and other antibiotics.

    Main Methods:

    • Twenty-five patients with Shigella flexneri 2a infection (including one mixed infection) were enrolled.
    • Patients were divided into four groups receiving varying ofloxacin regimens (intravenous/oral, once/twice daily, combination therapy) or non-ofloxacin antibiotics.
    • Clinical parameters, including body temperature, and pathogen eradication were monitored.

    Main Results:

    • Ofloxacin demonstrated high efficacy across all tested regimens, achieving rapid normalization of body temperature by day 2-3.
    • Complete eradication of Shigella flexneri 2a was observed in patients treated with ofloxacin.
    • Ofloxacin exhibited superior efficacy compared to other antibiotics used in the study.

    Conclusions:

    • Ofloxacin is a highly effective treatment for Shigella flexneri 2a dysentery.
    • The observed rapid clinical improvement and pathogen eradication support the use of ofloxacin as a primary therapeutic agent.

    More Related Videos

    High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence07:25

    High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence

    Published on: February 23, 2021

    Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli12:29

    Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli

    Published on: March 24, 2023

    Related Concept Videos

    Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

    Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

    Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

    Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
    Drugs for Treatment of Diarrhea-Predominant IBS01:17

    Drugs for Treatment of Diarrhea-Predominant IBS

    Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
    Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
    Drugs for Treatment of Ulcerative Colitis in IBD01:29

    Drugs for Treatment of Ulcerative Colitis in IBD

    Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
    Urinary Tract Infection IV: Nursing Management01:17

    Urinary Tract Infection IV: Nursing Management

    In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
    Inhibitors of Bacterial DNA Synthesis01:28

    Inhibitors of Bacterial DNA Synthesis

    Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...